U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: March 10-16, 2024
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: March 10-16, 2024

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 03/11/2024
Location: Washington, DC
Subject: International Medical Device Regulators Forum 25th Management Committee Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, media, government, academia, and other registered participants

Event Date: 03/12/2024
Location: Washington, DC
Subject: Us Against Alzheimer's and Friends of Cancer Research Celebration of Janet Woodcock
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Academia, industry, government, and other invited guests

Event Date: 03/13/2024
Location: Baltimore, MD
Subject: America's Health Insurance Plan 2024 Medicare, Medicaid, Duals and Commercial Markets Forum
FDA Participant/Group: DAYLE CRISTINZIO; CHERIE DUVALL JONES; INDIRA KONDURI;
Non FDA Participant/Group: Industry, government, media, and other registered participants

Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner

Event Date: 03/13/2024
Location: Washington, DC
Subject: AgencyIQ/POLITICO Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Lawmakers and industry leaders

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 03/11/2024
Location: College Park, MD
Subject: Introductory Meeting
FDA Participant/Group: JEFFREY FARRAR; CATHERINE MCDERMOTT; BARBARA CASSENS; ERIK METTLER; CONRAD CHOINIERE;
Non FDA Participant/Group: David Dyjack, Doug Farquhar (National Environmental Health Association);

Event Date: 03/15/2024
Location: Virtual
Subject: Food Traceability
FDA Participant/Group: REBECCA BUCKNER; KARI BARRETT; LARRY MORRIS; LAUREN FINNEGAN; DONALD PRATER;
Non FDA Participant/Group: Mala Parker, Mark S. Allen (International Foodservice Distributors Association);

Event Date: 03/15/2024
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: STELLA SPYROPOULOS; LARRY MORRIS; CONRAD CHOINIERE; PAUL SOUTH;
Non FDA Participant/Group: Laura Shumow (American Spice Trade Association);

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 03/14/2024
Location: Virtual
Subject: FDA's Policy Priorities for 2024
FDA Participant/Group: N/A
Non FDA Participant/Group: John Stone, Katie Williams (BGR Government Affairs, LLC);

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 03/11/2024
Location: Virtual
Subject: World Health Organization (WHO) Listed Authority Process
FDA Participant/Group: N/A
Non FDA Participant/Group: Rogerio Gaspar (World Health Organization);

Event Date: 03/12/2024
Location: Washington, DC
Subject: 25th Session of the International Medical Device Regulatory Forum; Speaker: The Role of FDA in Advancing International Harmonization and Fostering High Quality Product Standards Globally
FDA Participant/Group: N/A
Non FDA Participant/Group: Session participants of the 25th Session of the International Medical Device Regulatory Forum

Event Date: 03/15/2024
Location: Virtual
Subject: Preparations for the 2024 Global Health Regulatory Team Convening in Kigali, Rwanda in June 2024
FDA Participant/Group: N/A
Non FDA Participant/Group: Senior officials of the Bill and Melinda Gates Foundation

Event Date: 03/15/2024
Location: Washington, DC
Subject: Signing of the Confidentiality Commitment with the Pharmacy and Poisons Board (PPB), Ministry of Health, Kenya
FDA Participant/Group: KRISTAN CALLAHAN;
Non FDA Participant/Group: Fred Siyoi, Paulyne Wairimu (Pharmacy and Poisons Board (PBB));

Official Name: Michael Rogers, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 03/11/2024
Location: Virtual
Subject: Mutual Cooperation Between USP and FDA
FDA Participant/Group: N/A
Non FDA Participant/Group: Ronald Piervincenzi (US Pharmacopeia (USP)); ;

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 03/11/2024
Location: Miami Beach, FL
Subject: Leerink Partners 2024 Global Biopharma Conference; Keynote Speaker
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Leerink Partners 2024 Global Biopharma Conference

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 03/11/2024
Location: Washington, DC
Subject: 2024 International Medical Device Regulators Forum (IMDRF); Speaker: Welcome Address by IMDRF 2024 Chair
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, academia, and other stakeholders

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 03/14/2024
Location: Virtual
Subject: Tobacco User Fees
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several staff representing the Senate Health, Education, Labor and Pensions (HELP) Committee

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

Event Date: 03/14/2024
Location: Rockville, MD
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives of Elanco

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

Event Date: 03/10/2024
Location: Salt Lake City, UT
Subject: Society of Toxicology Annual Meeting; Attendee
FDA Participant/Group: Numorus FDA staff
Non FDA Participant/Group: Industry, academia, and general public

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

Back to Top